Home » Topics » BioWorld Science

BioWorld Science
RSS

ViiV Healthcare synthesizes prodrugs of HIV maturation inhibitors

Nov. 15, 2019

Janssen describes compounds for respiratory syncytial virus infections

Nov. 15, 2019

Preclinical data suggest MCLA-129 has potential for NSCLC resistant to EGFR-targeted therapies

Nov. 15, 2019

Preliminary phase I/II data for BMS-986148 monotherapy and combination with nivolumab

Nov. 15, 2019

Gilead presents phase II results for selgantolimod in patients with chronic HBV

Nov. 15, 2019

Hoth Therapeutics initiates preclinical testing of topical aprepitant

Nov. 15, 2019

First patient dosed in phase Ib/IIa proof-of-concept study of BRII-179

Nov. 15, 2019

Cerveau Technologies starts Japanese phase I study of [18F]MK-6240

Nov. 15, 2019

Arthrosi Therapeutics presents preclinical and phase I results for AR-882

Nov. 15, 2019

Sansheng's clinical trial application for HIF-117 capsules cleared in China

Nov. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...